PROQR THERAPEUTICS NV (PRQR)

NL0010872495 - Common Stock

3.62  +0.01 (+0.28%)

After market: 3.62 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
2.4M
-74.60%		4.8M
100.00%		9.525M
98.44%		26.299M
176.10%
EBITDA
YoY % growth
-54.86M
-37.12%		-62.2M
-13.38%		-29.346M
52.82%		-42.064M
-43.34%
EBIT
YoY % growth
-57.19M
-34.98%		-64.72M
-13.17%		-31.859M
50.77%		-35.807M
-12.39%
Operating Margin
-2,382.92%-1,348.33%-334.48%-136.15%
EPS
YoY % growth
-0.97
-5.43%		-0.91
6.19%		-0.35
61.54%		-0.31
10.57%

All data in EUR

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in EUR

Recent Earnings VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth		 -0.10
-42.86%		-0.110.017.09%
Q2 2024
Q2Q % growth		 -0.03
70.00%		-0.130.1076.42%
Q1 2024
Q2Q % growth		 -0.09
18.18%		-0.110.0219.45%
Q4 2023
Q2Q % growth		 -0.07
56.25%		0.01-0.08-732.51%
Q3 2023
Q2Q % growth		 -0.07
79.41%		-0.090.0219.37%
Q2 2023
Q2Q % growth
Q1 2023
Q2Q % growth
Q4 2022
Q2Q % growth
Q3 2022
Q2Q % growth
Q2 2022
Q2Q % growth
Q1 2022
Q2Q % growth
Q4 2021
Q2Q % growth
Q3 2021
Q2Q % growth
Q2 2021
Q2Q % growth
Q1 2021
Q2Q % growth
Q4 2020
Q2Q % growth
Q3 2020
Q2Q % growth
Q2 2020
Q2Q % growth
Q1 2020
Q2Q % growth
Q4 2019
Q2Q % growth
Q3 2019
Q2Q % growth
Q2 2019
Q2Q % growth
Q1 2019
Q2Q % growth
Q4 2018
Q2Q % growth
Q3 2018
Q2Q % growth
Q2 2018
Q2Q % growth
Q1 2018
Q2Q % growth
Recent Revenue VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth		 3.843M
180.51%		11.296M-7.453M-65.98%
Q2 2024
Q2Q % growth		 6.305M
407.65%		11.685M-5.38M-46.04%
Q1 2024
Q2Q % growth		 4.45M
579.39%		3.2M1.25M39.06%
Q4 2023
Q2Q % growth		 6.215M
374.43%		15.027M-8.812M-58.64%
Q3 2023
Q2Q % growth		 1.37M
53.93%		3.383M-2.013M-59.50%
Q2 2023
Q2Q % growth
Q1 2023
Q2Q % growth
Q4 2022
Q2Q % growth
Q3 2022
Q2Q % growth
Q2 2022
Q2Q % growth
Q1 2022
Q2Q % growth
Q4 2021
Q2Q % growth
Q3 2021
Q2Q % growth
Q2 2021
Q2Q % growth
Q1 2021
Q2Q % growth
Q4 2020
Q2Q % growth
Q3 2020
Q2Q % growth
Q2 2020
Q2Q % growth
Q1 2020
Q2Q % growth
Q4 2019
Q2Q % growth
Q3 2019
Q2Q % growth
Q2 2019
Q2Q % growth
Q1 2019
Q2Q % growth
Q4 2018
Q2Q % growth
Q3 2018
Q2Q % growth
Q2 2018
Q2Q % growth
Q1 2018
Q2Q % growth
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 15.91% -0.82% 34.01%
Revenue0% 294% -1.66% 17.03%